Glioblastoma Multiforme Treatment Market Analysis
The Glioblastoma Multiforme (GBM) Treatment Market, valued at USD 2.69 billion in 2023, is projected to experience substantial growth, reaching USD 5.68 billion by 2031. This expansion reflects a compound annual growth rate (CAGR) of 9.8% over the forecast period from 2024 to 2031.
Glioblastoma Multiforme, one of the most aggressive forms of...
English
Arabic
Français
Español
Português
Türkçe
Dutch
Italiano
Russian
Romaian